BHIPP Bulletin

Volume 11, Issue 3

September 2025

A Primer on the Assessment of Disruptive Behavior Disorders

This month's BHIPP Bulletin is a contribution from

Rheanna Platt, MD, Associate Professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine and BHIPP Consultant.

Disruptive behavior disorders (DBD) including Oppositional Defiant Disorder (ODD), Conduct Disorder (CD), and other conditions (e.g., Intermittent Explosive Disorder) are relatively common in childhood and adolescence, with an estimated prevalence of up to 10% for ODD (with a slightly lower estimated prevalence of CD).1 In this newsletter, we will review the assessment of youth with disruptive behavior, whether due to the aforementioned disorders or due to other contributing factors and/or disorders. Importantly, not all disruptive behavior is due to disruptive behavior disorders.   

According to the DSM-5-TR,2 ODD involves at least 6 months of symptomatology across three categories, including (a) angry/irritable mood; (b) argumentative/defiant behavior; and (c) vindictiveness, during interactions with “at least one individual who is not a sibling”. Symptoms must also cause impairment (including distress in the child and/or others) in at least one setting (e.g., home, school, with peers). Given that some degree of defiant behavior is common in children under 5, symptoms/behaviors must be present for most days in this age group, whereas behaviors must be present at least once per week for children 5 and older.2 ODD is more common in males than females prior to adolescence (with a more even distribution afterward), and first symptoms often appear during the preschool years.2 Importantly, ODD is often comorbid with other disorders; therefore, screening for comorbidities is critical, given the implications for treatment (e.g., use of medications for ADHD, additional supports for learning disabilities). The most common comorbid disorders with ODD include ADHD, substance use, learning disorders, and mood disorders (including depressive disorders, bipolar disorders, and disruptive mood dysregulation disorder).3  


An additional requirement for diagnosis of ODD is that the symptoms/disruptive behaviors are not solely due to the presence of another disorder. Anxiety disorders are often overlooked in the assessment/treatment of disruptive behavior. For example, a child with anxiety who is confronted with a feared stimulus (e.g., peers in the context of social anxiety) may engage in disruptive behavior either due to behavioral dysregulation and/or as an attempt to escape the feared item/situation/avoid the acute fear. Similarly, a patient with a trauma-related disorder may engage in disruptive or dysregulated behavior in the context of exposure to a reminder of the traumatic event. 


ODD often (but not always) precedes CD, which generally describes a more severe set of symptoms than ODD. The symptoms of CD occur across four domains: (a) aggression (i.e., physical, sexual, or threats/psychological) toward people and/or animals; (b) destruction of property; (c) deceitfulness or theft; and/or (d) serious rule violations (e.g., repeated truancy).2 CD can be further specified by onset, with childhood onset type being characterized by demonstration of at least one symptom by 10 years of age and adolescent onset characterized by no symptoms displayed prior to age 10.2 An additional specifier is the presence of so-called “callous-unemotional” traits (e.g., limited prosocial emotions, lack of remorse/guilt, lack of empathy, shallow/insincere display of emotions), which is associated with greater heritability, and generally with worse outcomes. Importantly, CD is also frequently comorbid with other disorders, including ADHD, substance use, learning disorders, and mood disorders. Of note, there is some evidence that individuals with CD have higher rates of suicidal thoughts and behaviors.4  


While there is some degree of heritability in both ODD and CD, there are also important and strong environmental risks for both disorders including exposure to violence, socioeconomic adversity, family factors (e.g., harsh discipline, parental rejection or neglect), and lower educational attainment, underscoring the importance of screening for (and addressing) risk factors (e.g., parenting challenges). CD is more common in males, and most commonly presents during middle childhood or adolescence.5  

In terms of screening, there are several freely available assessment tools. The Pediatric Symptom Checklist (PSC-17) contains an “externalizing” subscale which includes items that may suggest disruptive behaviors. The Strengths and Difficulties Questionnaire (SDQ) includes a “conduct problems” subscale as well as a “prosocial behavior” subscale. While slightly longer (25 questions), the SDQ also has several versions (by age, informant, etc). The Vanderbilt Assessment Scale (initial assessment, not follow-up) contains questions assessing both ODD and CD symptoms. 


For information on approaches to managing disruptive behavior, please see BHIPP’s November 2021 Newsletter.This newsletter also includes resource recommendations related to behavioral management of disruptive behavior. 

As always, if you have questions about the behavioral health needs of your patients, we encourage you to call the BHIPP consultation line at 

855-MD-BHIPP (632-4477), open 9am-5pm Monday-Friday, for resource/referral networking or consultation support.


We will keep you informed about all our services and training events through our website (www.mdbhipp.org) and monthly e-newsletters. Additionally, BHIPP is on LinkedIn and Facebook. We invite you to follow us there to stay up-to-date on upcoming training events, pediatric mental health research, and resources for providers, families and children.

BHIPP Announcements

Sign up for the BHIPP ECHO PMHNP Series!

Register for the new BHIPP PMHNP ECHO series! The first session will be held on October 7th from 11:00am-12:00pm. Join our multidisciplinary team of child behavioral health experts every month between October 2025 and May 2026 for virtual case-based learning and didactic presentations. This series is designed for Maryland Psychiatric-Mental Health Nurse Practitioners (PMHNPs) who want to deepen their knowledge of child and adolescent mental health.

Join the BHIPP ECHO Series for Pediatric Primary Care Providers!

Register for the BHIPP ECHO Series for Pediatric Primary Care Providers! The first session will be held on October 9th from 12:00-1:00pm. Join our multidisciplinary team of child behavioral health experts bimonthly from October 2025 and May 2026 for virtual case-based learning and didactic presentations. Free CEU, CME, and ABP MOC Part 2 credits are available for participation.

Register for the upcoming BHIPP Webinar!

Register for an upcoming BHIPP Webinar on October 30th at 12:00pm! BHIPP Webinars are a series of interactive, web-based learning sessions that are a virtual space for pediatric primary care, emergency medicine, and behavioral health providers to connect, learn and share about strategies, practices and resources to promote mental health and resilience among children and families as well as providers. Free CME and CEU credit is available for participation!

Facebook  Linkedin  Youtube

BHIPP is supported by funding from the Maryland Department of Health, Behavioral Health Administration and operates as a collaboration between the University of Maryland School of Medicine, the Johns Hopkins University School of Medicine, and Salisbury University.


BHIPP and this newsletter are also supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1,379,327 with approximately 20% financed by non-governmental sources. The contents of this newsletter are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government. For more information, visit www.hrsa.gov.


Copyright © 2021 Maryland Behavioral Health Integration in Pediatric Primary Care (BHIPP), All rights reserved.